Figure 1.
Differentially expressed skin genes and GO pathways after adalimumab treatment identified by RNAseq. A) Log 2 fold change of top 25 differentially expressed genes in the skin is listed. B) GO pathway term, p-value, false discovery rate (FDR) identified by DAVID enrichment analysis based on gene list.